It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 0 FA rating(s) are green whileMD’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 4 TA indicator(s) are bullish while MD’s TA Score has 3 bullish TA indicator(s).
ASTH (@Medical/Nursing Services) experienced а -10.44% price change this week, while MD (@Medical/Nursing Services) price change was +0.14% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.37%. For the same industry, the average monthly price growth was +0.82%, and the average quarterly price growth was +0.38%.
ASTH is expected to report earnings on Feb 20, 2025.
MD is expected to report earnings on Feb 13, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
ASTH | MD | ASTH / MD | |
Capitalization | 1.88B | 819M | 230% |
EBITDA | 124M | 29.9M | 415% |
Gain YTD | -12.010 | 51.505 | -23% |
P/E Ratio | 32.55 | 7.98 | 408% |
Revenue | 1.39B | 2B | 70% |
Total Cash | 296M | 178M | 166% |
Total Debt | 321M | 702M | 46% |
ASTH | MD | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 78 | 100 | |
SMR RATING 1..100 | 71 | 96 | |
PRICE GROWTH RATING 1..100 | 87 | 38 | |
P/E GROWTH RATING 1..100 | 91 | 97 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MD's Valuation (57) in the Medical Or Nursing Services industry is in the same range as ASTH (64) in the null industry. This means that MD’s stock grew similarly to ASTH’s over the last 12 months.
ASTH's Profit vs Risk Rating (78) in the null industry is in the same range as MD (100) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to MD’s over the last 12 months.
ASTH's SMR Rating (71) in the null industry is in the same range as MD (96) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to MD’s over the last 12 months.
MD's Price Growth Rating (38) in the Medical Or Nursing Services industry is somewhat better than the same rating for ASTH (87) in the null industry. This means that MD’s stock grew somewhat faster than ASTH’s over the last 12 months.
ASTH's P/E Growth Rating (91) in the null industry is in the same range as MD (97) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to MD’s over the last 12 months.
ASTH | MD | |
---|---|---|
RSI ODDS (%) | 3 days ago85% | N/A |
Stochastic ODDS (%) | 3 days ago82% | 3 days ago76% |
Momentum ODDS (%) | 3 days ago71% | 3 days ago74% |
MACD ODDS (%) | 3 days ago80% | 5 days ago79% |
TrendWeek ODDS (%) | 3 days ago74% | 3 days ago70% |
TrendMonth ODDS (%) | 3 days ago76% | 3 days ago74% |
Advances ODDS (%) | 21 days ago79% | 21 days ago70% |
Declines ODDS (%) | 5 days ago72% | 5 days ago74% |
BollingerBands ODDS (%) | 3 days ago83% | 3 days ago69% |
Aroon ODDS (%) | 3 days ago83% | 3 days ago74% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FMXSX | 7.57 | 0.09 | +1.20% |
Federated Hermes Max-Cap Index Svc | |||
LCEAX | 17.85 | 0.20 | +1.13% |
Invesco Diversified Dividend A | |||
MECAX | 42.62 | 0.30 | +0.71% |
AMG GW&K International Small Cap N | |||
REMYX | 16.04 | 0.03 | +0.19% |
Russell Inv Emerging Markets Y | |||
UGLSX | 75.02 | -9.72 | -11.47% |
JHancock U.S. Global Leaders Growth R6 |
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with AGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then AGL could also see price increases.
Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
---|---|---|---|---|
ASTH | 100% | -3.96% | ||
AGL - ASTH | 50% Loosely correlated | +4.79% | ||
AMN - ASTH | 50% Loosely correlated | -0.04% | ||
USPH - ASTH | 40% Loosely correlated | -0.11% | ||
NHC - ASTH | 39% Loosely correlated | -1.72% | ||
BKD - ASTH | 35% Loosely correlated | +2.60% | ||
More |